Jasper Therapeutics Inc. (JSPRW) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Jasper Therapeutics Inc.

    NASDAQ: JSPRW · Real-Time Price · USD
    0.09
    -0.01 (-14.29%)
    At close: Jun 09, 2025, 3:57 PM

    Jasper Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -71.27M -64.47M -37.69M -30.64M
    Depreciation & Amortization
    		 1.37M 1.11M 975K 377K
    Stock-Based Compensation
    		 6.62M 5.21M 4.09M 1.05M
    Other Working Capital
    		 295K 2.06M 1.5M -1.32M
    Other Non-Cash Items
    		 502K 976K -12.59M -9.09M
    Deferred Income Tax
    		 n/a n/a n/a 3M
    Change in Working Capital
    		 173K 5.1M -649K 1.62M
    Operating Cash Flow
    		 -62.6M -52.07M -45.86M -33.68M
    Capital Expenditures
    		 -552K -267K -576K -2.43M
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 20K n/a n/a n/a
    Investing Cash Flow
    		 -532K -267K -576K -2.43M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a 28K n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 689K -508K 55K 90.22M
    Financial Cash Flow
    		 47.88M 100.97M 55K 100.97M
    Net Cash Flow
    		 -15.25M 48.64M -46.38M 64.86M
    Free Cash Flow
    		 -63.15M -52.33M -46.43M -36.11M

    Add to Watchlist